Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis.

J. Schattenberg,Myung-Shik Lee

DOI: https://doi.org/10.1053/j.gastro.2016.02.064

IF: 29.4

2016-04-01

Gastroenterology

Abstract:75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 Nmost common liver disease in Europe, the United States, and major regions of Asia. The continuous increase of the underlying metabolic risk factors, including abdominal adiposity, insulin resistance/diabetes, and hyperlipidemia has put large populations at risk to develop advanced liver disease characterized by fibrosis or even cirrhosis. Although chronic viral hepatitis was the leading cause of hepatocellular carcinoma for a long time, currently NASH is becoming an increasingly important cause of end-stage liver disease. In the clinical context, this has led to a strong increase in the number of patients that were listed for liver transplantation owing to NASH in US centers. Despite this alarming increase, the available diagnostic and therapeutic options are limited. Current guidelines in several countries, including the US and Germany, point out that the mainstays of therapy are lifestyle interventions leading to weight loss and increased muscle mass, which are difficult to implement in the large target population. Thus, translational research and improved therapies are urgently required, and research consortia have been formed in the United States, namely, the NASH clinical research network and in Europe, namely, the consortium for Elucidating Pathways of Steatohepatitis to address this shortcoming. The pathophysiology of NASH involves 2 cardinal features: hepatocellular injury from lipotoxicity and associated inflammation. However, it remains unclear how mere lipid overload may promote or even cause hepatocellular injury and inflammation. The 2 (or more)-hit model has been proposed implicating the involvement of 2 critical events in the development of NASH. Especially, increased oxidative stress, endotoxemia, or cytokines have been incriminated in the progression from nonalcoholic fatty liver to NASH. In this issue of Gastroenterology, Hirsova et al present an intriguing view that hepatocellular events may lead to macrophage activation and inflammation via the release of extracellular vesicles (EVs) as a consequence of lipidassociated toxicity. EVs serve as shuttles for membrane and cytosolic components between cells and can either bud from the plasma membrane (microvesicles) or be formed intracellularly as multivesicular endosome that are secreted (exosomes). These EVs may also qualify as novel serum biomarkers, as shown for immune cell–specific EVs (microparticles) that have been shown to correlate with